Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2004-06-10
2010-06-08
Chang, Celia (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S129000, C546S197000
Reexamination Certificate
active
07732464
ABSTRACT:
The present invention is concerned with novel compounds of formula (I) having 5HT4-antagonistic properties. The invention further relates to methods for preparing such novel compounds, pharmaceutical compositions comprising said novel compounds as well as the use as a medicine of said compounds.
REFERENCES:
patent: 4186135 (1980-01-01), Thominet et al.
patent: 6544997 (2003-04-01), Bosmans et al.
patent: WO 93/05038 (1993-03-01), None
patent: WO 00/37461 (2000-06-01), None
patent: WO2004/017960 (2004-03-01), None
Patani et al. “Bioisoterism: a rational approach in drug design” Chem. Rev. v.96, p. 3147-3176 (1996).
Search report for International Application No. PCT/EP/2004/006273.
Bosmans Jean-Paul Rene Marie Andre
Gijsen Henricus Jacobus Maria
Mevellec Laurence Anne
Chang Celia
Janssen Pharmaceutica N.V.
Woodcock & Washburn LLP
LandOfFree
Heterocyclic substituted 4-(aminomethyl)-piperidine... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic substituted 4-(aminomethyl)-piperidine..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic substituted 4-(aminomethyl)-piperidine... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4184960